These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 18035066)

  • 21. Thiazolidinediones in type 2 diabetes: a cardiology perspective.
    Khanderia U; Pop-Busui R; Eagle KA
    Ann Pharmacother; 2008 Oct; 42(10):1466-74. PubMed ID: 18698014
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapies for type 2 diabetes and coronary artery disease.
    DeVries JH
    N Engl J Med; 2009 Oct; 361(14):1408-9; author reply 1409-10. PubMed ID: 19802918
    [No Abstract]   [Full Text] [Related]  

  • 23. Metformin use and mortality among patients with diabetes and atherothrombosis.
    Roussel R; Travert F; Pasquet B; Wilson PW; Smith SC; Goto S; Ravaud P; Marre M; Porath A; Bhatt DL; Steg PG;
    Arch Intern Med; 2010 Nov; 170(21):1892-9. PubMed ID: 21098347
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Metformin and heart failure: never say never again.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2012 Jan; 13(1):1-8. PubMed ID: 22149365
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type 2 diabetes mellitus and heart failure.
    Choy CK; Rodgers JE; Nappi JM; Haines ST
    Pharmacotherapy; 2008 Feb; 28(2):170-92. PubMed ID: 18225964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin: diamonds are forever.
    Papanas N; Maltezos E; Mikhailidis DP
    Expert Opin Pharmacother; 2009 Oct; 10(15):2395-7. PubMed ID: 19678795
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Getting an extension.
    Diabetes Obes Metab; 2002 Mar; 4(2):139-40. PubMed ID: 11993444
    [No Abstract]   [Full Text] [Related]  

  • 28. Metformin reduces circulating factor VII concentrations in patients with type 2 diabetes mellitus.
    Grant PJ
    Thromb Haemost; 1998 Jul; 80(1):209-10. PubMed ID: 9684819
    [No Abstract]   [Full Text] [Related]  

  • 29. Islet enhancer vildagliptin: a powerful partner with metformin for the treatment of patients with type 2 diabetes.
    Scherbaum WA
    Diabetes Obes Metab; 2009 May; 11 Suppl 2():1-2. PubMed ID: 19385977
    [No Abstract]   [Full Text] [Related]  

  • 30. The safety of metformin in heart failure.
    Roberts F; Ryan GJ
    Ann Pharmacother; 2007 Apr; 41(4):642-6. PubMed ID: 17374622
    [TBL] [Abstract][Full Text] [Related]  

  • 31. New treatments for diabetes.
    Raz I; Eldor R
    N Engl J Med; 2007 May; 356(21):2222; author reply 2222-3. PubMed ID: 17526096
    [No Abstract]   [Full Text] [Related]  

  • 32. Metformin: fifty-two not out.
    Campbell IW
    J Indian Med Assoc; 2009 Nov; 107(11):779-84. PubMed ID: 20469782
    [No Abstract]   [Full Text] [Related]  

  • 33. Metformin and thiazolidinedione use in Medicare patients with heart failure.
    Masoudi FA; Wang Y; Inzucchi SE; Setaro JF; Havranek EP; Foody JM; Krumholz HM
    JAMA; 2003 Jul; 290(1):81-5. PubMed ID: 12837715
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metformin discontinuation rate among patients with type-2 diabetes mellitus in Basrah, Iraq.
    Mansour AA; Habib OS
    Saudi Med J; 2007 Dec; 28(12):1919-21. PubMed ID: 18060234
    [No Abstract]   [Full Text] [Related]  

  • 35. Diabetes in the new General Medical Services contract: targets and adherence to metformin therapy.
    Kirby M
    Int J Clin Pract; 2005 Mar; 59(3):263-6. PubMed ID: 15857318
    [No Abstract]   [Full Text] [Related]  

  • 36. Follow-up of intensive glucose control in type 2 diabetes.
    Petrie JR
    N Engl J Med; 2009 Jan; 360(4):416-7; author reply 418. PubMed ID: 19172672
    [No Abstract]   [Full Text] [Related]  

  • 37. To: Holstein A, Stumvoll M (2005) Contraindications can damage your health--is metformin a case in point? Diabetologia 48:2454-2459.
    Ma RC; Chow CC; Tong PC; Chan JC; Cockram CS
    Diabetologia; 2006 May; 49(5):1127-8. PubMed ID: 16565848
    [No Abstract]   [Full Text] [Related]  

  • 38. Follow-up of intensive glucose control in type 2 diabetes.
    Mühlhauser I
    N Engl J Med; 2009 Jan; 360(4):417; author reply 418. PubMed ID: 19172674
    [No Abstract]   [Full Text] [Related]  

  • 39. Preventing nephropathy induced by contrast medium.
    Gross JL; Friedman R; Silveiro SP
    N Engl J Med; 2006 Apr; 354(17):1853-5; author reply 1853-5. PubMed ID: 16641408
    [No Abstract]   [Full Text] [Related]  

  • 40. Metformin: 50 years old, fit as a fiddle, and indispensable for its pivotal role in type 2 diabetes management.
    Halimi S
    Diabetes Metab; 2006 Dec; 32(6):555-6. PubMed ID: 17296508
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.